We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
+30.91%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$1.29B
AUM Growth
+$94.4M
Cap. Flow
-$78.5M
Cap. Flow %
-6.1%
Top 10 Hldgs %
48.93%
Holding
207
New
56
Increased
31
Reduced
35
Closed
51

Top Buys

Rank Stock Value
1
IOVA icon
Iovance Biotherapeutics
IOVA
+$30.6M
2
QURE icon
uniQure
QURE
+$18.4M
3
NVRO
NEVRO CORP.
NVRO
+$16.5M
4
TVTX icon
Travere Therapeutics
TVTX
+$12.9M
5
ARAV
Aravive, Inc. Common Stock
ARAV
+$12M

Top Sells

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$34.8M
2
RCPT
RECEPTOS INC COM STK (DE)
RCPT
+$21.8M
3
ESPR
Esperion Therapeutics
ESPR
+$19.5M
4
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$19.3M
5
TARO
Taro Pharmaceutical Industries Ltd.
TARO
+$18.5M

Sector Composition

Rank Sector Weight
1 Healthcare 84.11%
2 Miscellaneous 14.93%
3 Consumer Staples 0.85%
4 Technology 0.05%
5 Financials 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLRN
26
DELISTED
Acceleron Pharma
XLRN
$12.8M 0.99%
336,036
+18,400
+6% +$732K
THOR
27
DELISTED
THORATEC CORPORATION
THOR
$12.6M 0.98%
300,000
-92,465
-24% -$3.53M
SGMO
28
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$12.5M 0.97%
800,000
– –
INSM icon
29
Insmed
INSM
$26.2B
$12.2M 0.95%
585,812
-100,000
-15% -$1.76M
NEPT
30
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$10.9M 0.85%
4,822
– –
QTNT
31
DELISTED
Quotient Limited Ordinary Shares
QTNT
$10.7M 0.83%
13,772
+2,425
+21% +$1.53M
AEGR
32
DELISTED
Aegerion Pharmaceuticals
AEGR
$9.97M 0.78%
+381,100
New +$9.7M
SRPT icon
33
CALL
Sarepta Therapeutics
SRPT
$2.19B
$9.96M 0.77%
750,000
+300,000
+67% +$4M
ELGX
34
DELISTED
Endologix Inc
ELGX
$9.64M 0.75%
56,500
+35,500
+169% +$5.38M
EIGR
35
CALL
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$8.99M 0.7%
+1,054
New +$9.21M
ZSPH
36
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$7.86M 0.61%
+186,777
New +$8.54M
BIIB icon
37
Biogen
BIIB
$31.9B
$7.68M 0.6%
+18,200
New +$7.17M
SHPG
38
DELISTED
Shire pic
SHPG
$7.18M 0.56%
30,000
+20,000
+200% +$4.6M
ANTH
39
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$7.17M 0.56%
200,395
+137,500
+219% +$4.07M
VBIV
40
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$6.79M 0.53%
+87,012
New +$7.76M
DYAX
41
PUT
DELISTED
DYAX CORPORATION
DYAX
$6.7M 0.52%
+400,000
New +$6.23M
CBPO
42
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$6.69M 0.52%
70,000
-4,023
-5% -$301K
AGTC
43
DELISTED
Applied Genetic Technologies Corporation
AGTC
$6.02M 0.47%
301,222
– –
ADYX
44
DELISTED
Adynxx Inc
ADYX
$5.83M 0.45%
18,699
– –
ASMB icon
45
Assembly Biosciences
ASMB
$532M
$5.63M 0.44%
+35,417
New +$4.79M
ELDN icon
46
Eledon Pharmaceuticals
ELDN
$220M
$5.48M 0.43%
2,829
-167
-6% -$368K
CPRX
47
DELISTED
Catalyst Pharmaceutical
CPRX
$5.2M 0.4%
+1,200,000
New +$4.33M
GNMX
48
DELISTED
Aevi Genomic Medicine Inc
GNMX
$5.15M 0.4%
639,225
+125,001
+24% +$943K
FPRX
49
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$5.12M 0.4%
224,129
+68,873
+44% +$1.74M
AFMD
50
DELISTED
Affimed
AFMD
$5.08M 0.39%
80,582
-20,000
-20% -$1.24M
1
2
3 4 5

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q1 2015 Portfolio in Review

As of Q1 2015, Perceptive Advisors held 207 positions worth $1.29B, up 7.9% from $1.19B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Perceptive Advisors withdrew a net $78.5M in Q1 2015, closing 51 positions and reducing 35 holdings. Its most notable exit was PTC Therapeutics, an estimated $34.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 80% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, Perceptive Advisors opened a new position in Iovance Biotherapeutics worth $32.9M.

  • Perceptive Advisors's largest Q1 2015 buy was Iovance Biotherapeutics: 2,714,549 shares worth $32.9M.
  • Perceptive Advisors added most to uniQure in Q1 2015, an estimated $18.4M increase.
  • Perceptive Advisors's biggest Q1 2015 reduction was RECEPTOS INC COM STK (DE), cutting an estimated $21.8M.
  • Perceptive Advisors fully exited PTC Therapeutics in Q1 2015, selling an estimated $34.8M.
  • Perceptive Advisors's ten largest holdings make up 49% of its $1.29B portfolio in Q1 2015.
  • Perceptive Advisors opened 56 new positions and closed 51 in Q1 2015.
  • Perceptive Advisors's portfolio value rose 7.9% quarter-over-quarter to $1.29B.

Based on Perceptive Advisors's 13F filing for Q1 2015, filed 15 May 2015.